|Bid||194.02 x 800|
|Ask||194.02 x 1000|
|Day's range||191.15 - 194.29|
|52-week range||124.60 - 231.36|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||1.88 (0.98%)|
|Ex-dividend date||15 Jun 2020|
|1y target est||N/A|
Shares of cleaning and sanitizing giant Ecolab (NYSE: ECL) lost nearly 9% of their value on Tuesday following its release of second-quarter 2020 earnings. While COVID-19-related demand boosted Ecolab's healthcare and life sciences segment revenue, the momentum wasn't enough to offset weakness in other major business lines. Ecolab's revenue declined 15% against the prior-year period to $2.7 billion, while net income plunged from a profit of $369 million to a loss of $2 billion.
ECL earnings call for the period ending June 30, 2020.
Ecolab's (ECL) second-quarter results reflect weakness in the Global Industrial and Institutional segments.